1.
Brandi H, Schneider S, Ryttig L. Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. J of Skin [Internet]. 2024Jan.16 [cited 2025Jan.20];8(1):s320. Available from: https://skin.dermsquared.com/skin/article/view/2401